Plunkett Research Online: Mayne Pharma Group

MAYNE PHARMA GROUP (MAYNF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Mayne Pharma is a small generics and specialty pharmaceutical manufacturer that earns over 90% of revenue in the U.S. market. Product portfolios focus on dermatology and women’s health. The company performs very limited research and development, typically acquiring off-patent or tail-end brands. In .....



Mayne Pharma Group
Ticker: MAYNF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 61 386147777
Fax: 61 396147022
Address: 1538 Main North Road
Salisbury South
Salisbury, SA 5106 Australia

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
Contacts Description
Shawn O’BrienCEO/Director/Managing Director
Frank CondellaChairman of the Board/Director
See More
Mayne Pharma is a small generics and specialty pharmaceutical manufacturer that earns over 90% of revenue in the U.S. market. Product portfolios focus on dermatology and women’s health. The company performs very limited research and development, typically acquiring off-patent or tail-end brands. In .....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: